Vitamine D in Multiple Sclerosis

Summary

Vitamine D in Multiple Sclerosis is a clinical trial^[1].

Key Facts

• Vitamine D in Multiple Sclerosis's instance of is recorded as clinical trial^[2].
• Vitamine D in Multiple Sclerosis's start time is recorded as +2013-03-31T00:00:00Z^[3].
• Vitamine D in Multiple Sclerosis's end time is recorded as +2014-08-31T00:00:00Z^[4].
• Vitamine D in Multiple Sclerosis's sponsor is recorded as Mazandaran University of Medical Sciences^[5].
• Vitamine D in Multiple Sclerosis's main subject is recorded as sclerosis^[6].
• Vitamine D in Multiple Sclerosis's main subject is recorded as multiple sclerosis^[7].
• Vitamine D in Multiple Sclerosis's number of participants is recorded as {'unit': '1', 'amount': '+240'}^[8].
• Vitamine D in Multiple Sclerosis's title is recorded as Randomised Double Blind Placebo-controlled Trial of Vitamine D Supplement in Multiple Sclerosis^[9].
• Vitamine D in Multiple Sclerosis's short name is recorded as MSVit^[10].
• Vitamine D in Multiple Sclerosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Vitamine D in Multiple Sclerosis's ClinicalTrials.gov ID is recorded as NCT01768039^[12].
• Vitamine D in Multiple Sclerosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[13].
• Vitamine D in Multiple Sclerosis's research intervention is recorded as (5R)-24,25-Dihydroxyvitamin D^[14].
• Vitamine D in Multiple Sclerosis's clinical trial phase is recorded as phase III clinical trial^[15].
• Vitamine D in Multiple Sclerosis's research site is recorded as Mazandaran University of Medical Sciences, Faculty of Health^[16].
• Vitamine D in Multiple Sclerosis's study type is recorded as interventional study^[17].